UNSPSC 51151619: Anisotropine

This classification denotes an antimuscarinic agent with the molecular formula C16H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MJJ5G1G8OM. As of Q4 2014, ANISOTROPINE remains the US FDA Preferred Term for this commodity. Anisotropine bears US NLM identifiers UMLS ID C0301369 and NCI Concept Code C87426. SMILES: CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[BR-]..

UNSPSC 51151619 Anisotropine is a Commodity code that in practice covers pharmaceutical products and related delivery systems procured by state and local health agencies. Recent solicitations under this code show state and local governments buying naloxone (opioid-reversal medication) and drug deactivation systems for community health programs, as well as exploring direct-to-manufacturer prescription fulfillment models to improve pharmacy benefit program efficiency. The issuing bodies include county health departments and state health and human services commissions; Seminole County, Florida and the Texas Health and Human Services Commission appear as recent active buyers.

Activity under this code centers on Florida and Texas. Seminole County, Florida issued an IFB (No. IFB60459723LAS) posted June 30, 2026, seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023, on a two-year contract with one-year renewal option. The Texas Health and Human Services Commission issued an RFI (No. HHS0017013) posted April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs aimed at improving cost management and fulfillment efficiency outside traditional pharmacy benefit manager and wholesaler channels. Both procurements require vendors to meet standard compliance obligations including E-Verify, drug-free workplace certification, and insurance requirements; neither specifies set-aside designations.